Definitive Contract W911QY17C0064
Award Date 6/30/17
Potential Completion Date 10/31/18
Potential Value $2.4M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $5,699,486.00 federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Sanaria Inc., a for-profit, veteran-owned business and manufacturer. The contract is for research and development services, with a performance period ending on October 31, 2018. Sanaria Inc. has provided services such as asexual malaria blood culture, clinical trial services for an investigational malaria vaccine, and research and development of P. falciparum sporozoite vaccines. This...
- This is a $3,397,349.60 fixed-price level of effort contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Sanaria Inc., a veteran-owned biotechnology company, for a Phase III clinical trial of an investigational malaria vaccine. The contract is for the production and delivery of Plasmodium falciparum sporozoites, the parasite that causes malaria, to support the clinical trial. Sanaria Inc. has previously provided services to the National Institutes of Health and...
- This $303,590.36 firm fixed price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Sanaria Inc., a for-profit organization and veteran-owned business that manufactures goods. The contract is for a 24-month malaria culture service to provide asexual malaria blood stage cultures and enriched late-stage gametocyte cultures to support malaria drug development efforts. This award is not associated...
- This is a $9,468,085.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Sanaria Inc., a for-profit, veteran-owned business, for the Phase II development of a malaria vaccine. The contract, which is not set aside, is focused on the continued research, development, and manufacturing of Sanaria's investigational Plasmodium falciparum sporozoite (PfSPZ) vaccine. This includes process improvements, non-clinical studies, and clinical trials in the U.S.,...
- This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Sanaria Inc., a biotechnology company focused on the development of malaria vaccines. The $149,931.25 firm-fixed-price purchase order is for the delivery of purified, vialed, and cryopreserved products, with a period of performance ending on February 29, 2016. Sanaria Inc. has previously received federal grants and contracts related to the research, development, and...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Sanaria Inc., a veteran-owned biotechnology company, for the development of a "Delivery System for Cryopreserved Eukaryotic Cell Vaccines." The potential value of this definitive, firm fixed-price contract is $149,994.23. Sanaria Inc. has prior experience providing services to support malaria drug development and vaccine clinical trials for federal agencies...
- <p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for "Delivery System for Cryopreserved Eukaryotic Cell Vaccines" research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $89,054.88 firm fixed price purchase order to Sanaria Inc. to provide asexual malaria blood culture service. The contract calls for monthly delivery of Plasmodium falciparum asexual parasites at over 90% ring stage, complete culture medium, and human blood for use in the National Center for Translational Sciences' malaria viability assays to support...
This is a $2,399,997.00 federal contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a for-profit, veteran-owned biotechnology company that manufactures goods. The contract is for research and development services, including providing asexual malaria blood culture service and conducting phase III clinical trials for an investigational malaria vaccine involving Plasmodium falciparum sporozoites. Sanaria Inc. has also received grants from the National Institutes of Health's National Institute of Allergy and Infectious Diseases for research, development, and manufacturing of P. falciparum sporozoite vaccines. This contract does not have a set-aside designation.
Generated 3/23/24, 9:10 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Malaria Vaccine Research and Development | W911QY-17-R-MVRD2 | Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground | Award Notice 2/2 | 7/6/17, 10:16 AM | |
Malaira Vaccine Research and Development | W911QY-17-R-MVRD2 | Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground | Award Notice 1/2 | 3/13/17, 1:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4m | 6/30/17 |